Most Read Articles
Jairia Dela Cruz, 3 days ago
Metabolic and bariatric surgery (MBS) leads to large and sustained reductions in, and even reversal of, multiple risk factors for future joint disease in adolescents with severe obesity and musculoskeletal pain, according to data from the Teen Longitudinal Assessment of Bariatric Surgery study.
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 6 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.

ELISA better than radioimmunoassay for GADAb detection in type 1 diabetes

05 Dec 2019

An enzyme-linked immunosorbent assay (ELISA) is better at detecting glutamic acid decarboxylase antibodies (GADAb) than the previously utilized radioimmunoassay (RIA) in childhood-onset type 1 diabetes mellitus (T1DM), a new study has found.

The study involved serum specimens from 1,024 Japanese patients (median age at diagnosis, 7 years; 598 girls). All samples underwent both ELISA and RIA for the measurement of GADAb levels. Samples were collected at a median age of 13 years.

The concordance rate between the two methods went as low as 77 percent. Samples were more likely to test positively for GADAb when collected within 5 years of the diagnosis. In those whose measurements were collected between 6 and 17 years after being diagnosed with T1DM, positivity rates were 31.1 percent and 50.5 percent for RIA and ELISA, respectively.

In comparison, the corresponding positivity rates were 47.9 percent and 69.4 percent in patients whose serum specimens were collected within 5 years of diagnosis.

“We demonstrated that the positivity rate for GADAb increased by approximately 20 percent, from 50 percent to 70 percent, by changing the assay method from RIA to ELISA in Japanese children and adolescents with T1D,” said researchers.

This may be explained by a stronger sensitivity of detection by the ELISA kit, they added. “The cutoff value for the ELISA kit was equivalent to 0.88 U/mL using the RIA kit, which is below the cutoff value [of 1.5 U/mL] for the RIA kit.” In practical terms, using the ELISA kit may help detect patients positive for GADAb who may have otherwise been missed by RIA.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 3 days ago
Metabolic and bariatric surgery (MBS) leads to large and sustained reductions in, and even reversal of, multiple risk factors for future joint disease in adolescents with severe obesity and musculoskeletal pain, according to data from the Teen Longitudinal Assessment of Bariatric Surgery study.
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 6 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.